Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Clinical trial NCT00715689 · COMPLETED

Trial details

NCT number: NCT00715689
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Growth Hormone Disorder Adult Growth Hormone Deficiency

Start date: 2008-07-01
Primary completion: 2009-03-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.